Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Duke University |
---|---|
Information provided by: | Duke University |
ClinicalTrials.gov Identifier: | NCT00526747 |
Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.
Condition |
---|
Anemia Kidney Failure Erythropoietin |
Study Type: | Observational |
Official Title: | Novel Biomarkers of Erythropoietin Resistant Anemia Among Patients With Chronic Kidney Disease |
Estimated Enrollment: | 32 |
Study Start Date: | August 2007 |
Study Completion Date: | June 2008 |
Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
Epo-resistant
Patients with CKD (estimated GFR < 60cc/min) not on hemodialysis who are receiving greater than or equal to 100IU/kg/week of epoetin alpha and/or 1mcg/kg/week darbepoetin to obtain target hemoglobin or hematocrit.
|
Epo-responsive
Patients with CKD (estimated GFR < 60cc/min) not on hemodialysis who are requiring <100IU/kg/week of epoetin alpha and/or 1mcg/kg/week of darbepoetin to obtain target hemoglobin/hematocrit.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
CKD anemia clinic patients
Inclusion Criteria:
Exclusion Criteria:
United States, North Carolina | |
Duke University Medical Center Anemia Clinic | |
Durham, North Carolina, United States, 27705 | |
Durham Nephrology Anemia Clinic | |
Durham, North Carolina, United States, 27704 |
Principal Investigator: | Jula Inrig, MD, MHS | Duke University |
Principal Investigator: | Lynda Szczech, MD | Duke University |
Principal Investigator: | Suzanne K Bryskin, MD | Duke University |
Responsible Party: | Duke University Medical Center ( Jula Inrig, MD ) |
Study ID Numbers: | 8578-07-6R1ER |
Study First Received: | September 6, 2007 |
Last Updated: | November 6, 2008 |
ClinicalTrials.gov Identifier: | NCT00526747 |
Health Authority: | United States: Institutional Review Board |
Epoetin Alfa Renal Insufficiency Urologic Diseases Hematologic Diseases Renal Insufficiency, Chronic |
Anemia Kidney Failure, Chronic Kidney Diseases Kidney Failure |